Specifically, we observed a significant down-regulation of some of the most relevant genes in the PPAR pathway (CD36, FABP4, PLIN1, PLIN4, SCD5 and ACSL4) in tumor tissue samples. The gene discussed is FABP4; the disease is neoplasm.